{"nct_id":"NCT00320710","title":"Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer","status":"COMPLETED","status_verified_date":"2014-08","start_date":"2006-02","start_date_type":null,"primary_completion_date":"2013-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}